Načítá se...

Hepatitis C virus NS5A inhibitors and drug resistance mutations

Some direct-acting antiviral agents for hepatitis C virus (HCV), such as telaprevir and boceprevir have been available since 2011. It was reported that HCV NS5A is associated with interferon signaling related to HCV replication and hepatocarcinogenesis. HCV NS5A inhibitors efficiently inhibited HCV...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Nakamoto, Shingo, Kanda, Tatsuo, Wu, Shuang, Shirasawa, Hiroshi, Yokosuka, Osamu
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Co., Limited 2014
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3961994/
https://ncbi.nlm.nih.gov/pubmed/24659881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i11.2902
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!